1. Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia
by Sebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, Michael D. Radmacher, Krzysztof Mrózek, Kati Maharry, Heiko Becker, Klaus H. Metzeler, Susan P. Whitman, Yue-Zhong Wu, Bayard L. Powell, Maria R. Baer, Jonathan E. Kolitz, Andrew J. Carroll, Richard A. Larson, Michael A. Caligiuri, and Clara D. Bloomfield
Blood
Volume 118(15):
October 13, 2011
©2011 by American Society of Hematology

2. Outcome of CN-AML patients 60 years of age or older with respect to MN1 expression.
Outcome of CN-AML patients 60 years of age or older with respect to MN1 expression. (A) OS. (B) EFS.
Sebastian Schwind et al. Blood 2011;118:
©2011 by American Society of Hematology

3. Outcome of CN-AML patients 70 years of age or older with respect to MN1 expression and NPM1 mutation status.
Outcome of CN-AML patients 70 years of age or older with respect to MN1 expression and NPM1 mutation status. (A) OS. (B) EFS.
Sebastian Schwind et al. Blood 2011;118:
©2011 by American Society of Hematology

4. Outcome of CN-AML patients 60 years of age or older with respect to MN1 expression within the ELN Favorable and ELN Intermediate-I genetic groups.
Outcome of CN-AML patients 60 years of age or older with respect to MN1 expression within the ELN Favorable and ELN Intermediate-I genetic groups. (A) OS. (B) EFS.
Sebastian Schwind et al. Blood 2011;118:
©2011 by American Society of Hematology

5. Heat map of the derived gene expression signature associated with MN1 expression in the group of CN-AML patients 60 years of age or older.
Heat map of the derived gene expression signature associated with MN1 expression in the group of CN-AML patients 60 years of age or older. The patients are ordered from left to right by increasing expression of MN1. Expression values of the probe sets are represented by color: blue represents expression less than the median value for the given probe set; and red, expression greater than the median value for the given probe set. Up- and down-regulated genes that are mentioned in the text are indicated along the side.
Sebastian Schwind et al. Blood 2011;118:
©2011 by American Society of Hematology

6. Heat map and table of the derived microRNA expression signature associated with MN1 expression in the group of CN-AML patients 60 years of age or older.
Heat map and table of the derived microRNA expression signature associated with MN1 expression in the group of CN-AML patients 60 years of age or older. (A) Heat map of the derived microRNA expression signature associated with MN1 expression in the group of CN-AML patients 60 years of age or older. The patients are ordered from left to right by increasing expression of MN1. Expression values of the probe sets are represented by color: blue represents expression less than the median value for the given probe; and red, expression greater than the median value for the given probe. Up- and down-regulated genes and microRNAs are indicated along the side. (B) Tables showing fold changes of the microRNAs that form the signature with corresponding fold changes.
Sebastian Schwind et al. Blood 2011;118:
©2011 by American Society of Hematology